Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.

Journal of hepatology - 1 Dec 2012

Furusyo Norihiro, Ogawa Eiichi, Sudoh Masayuki, Murata Masayuki, Ihara Takeshi, Hayashi Takeo, Ikezaki Hiroaki, Hiramine Satoshi, Mukae Haru, Toyoda Kazuhiro, Taniai Hiroaki, Okada Kyoko, Kainuma Mosaburo, Kajiwara Eiji, Hayashi Jun

Abstract excerpt

BACKGROUND & AIMS: Early menopause in women with chronic hepatitis C virus (HCV) infection is associated with a low likelihood of a sustained virological response (SVR) in conjunction with their antiviral treatment. This is potentially related to their reduced estrogen secretion. The study was done to determine whether selective estrogen receptor modulator administration might improve the efficacy of the current...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis C, Chronic
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferons

Share to Interleukins

Share to Polyethylene Glycols

Share to Postmenopause

Share to Ribavirin

Share to Selective Estrogen Receptor Modulators

Source

Identifiers

PMID: 22889955
DOI: 10.1016/j.jhep.2012.08.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.PMID 22889955Read ↗

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.Semantic proximity Read ↗

Sex-specific association of estrogen receptor 2 polymorphisms with hepatitis C virus infection outcomes in a high-risk Chinese Han population.Semantic proximity Read ↗

Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle.Semantic proximity Read ↗

Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular CarcinomaSemantic proximity Read ↗

A Lower PBMC Estrogen Receptor α Gene Expression in Chronic Hepatitis B Is Associated with a Sustained Virological Response to Pegylated Interferon.Semantic proximity Read ↗

Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.Semantic proximity Read ↗

Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort.Semantic proximity Read ↗

Polymorphism of estrogen receptor alpha (ESR1) is associated with virological response to entecavir (ETV) in nucleoside-naïve adult patients with chronic hepatitis B.Semantic proximity Read ↗

Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donorsSemantic proximity Read ↗

Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads.Semantic proximity Read ↗

Association of genetic variants in estrogen receptor α with HCV infection susceptibility and viral clearance in a high-risk Chinese population.Semantic proximity Read ↗

Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.